Complement factor C4d Is a common denominator in thrombotic microangiopathy

Journal of the American Society of Nephrology

Volumn 26, Issue 9, 2015, Pages 2239-2247

  Chua, Jamie S ^a   Baelde, Hans J ^a   Zandbergen, Malu ^a   Wilhelmus, Suzanne ^a   Van Es, Leendert A ^a   De Fijter, Johan W ^a   Bruijn, Jan A ^a   Bajema, Ingeborg M ^a   Cohen, Danielle ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLOSPORIN; IMMUNOGLOBULIN M; LECTIN; MANNOSE BINDING LECTIN; TACROLIMUS; BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD VESSEL PARAMETERS; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOXICITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MALIGNANT HYPERTENSION; MEDICAL HISTORY; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEGENER GRANULOMATOSIS; ARTERIOLE; CAPILLARY; CHEMISTRY; COMPLEMENT CLASSICAL PATHWAY; COMPLICATION; GLOMERULUS; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; ARTERIOLES; BIOMARKERS; CAPILLARIES; CHILD; COMPLEMENT C1Q; COMPLEMENT C4B; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, CLASSICAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; KIDNEY DISEASES; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PEPTIDE FRAGMENTS; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 84929518595     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050429     Document Type: Article

References (31)

1. Moake JL: Thrombotic microangiopathies.NEngl JMed 347: 589-600, 2002
2. Tsai HM: The molecular biology of thrombotic microangiopathy. Kidney Int 70: 16-23, 2006
3. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB; European Paediatric Research Group for HUS: A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70: 423-431, 2006
4. George JN, Nester CM: Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654-666, 2014
5. Noris M, Mescia F, Remuzzi G: STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8: 622-633, 2012
6. Noris M, Remuzzi G: Atypical hemolytic-uremic syndrome. N Engl J Med 361: 1676-1687, 2009
7. Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C: Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187: 172-180, 2011
8. Ruiz-Torres MP, Casiraghi F, Galbusera M, Macconi D, Gastoldi S, Todeschini M, Porrati F, Belotti D, Pogliani EM, Noris M, Remuzzi G: Complement activation: The missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies. Thromb Haemost 93: 443-452, 2005
9. Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, Roos van Groningen M, Steup-Beekman GM, de Heer E, Bruijn JA, Bajema IM: Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 58: 2460-2469, 2008
10. Seshan SV, Franzke CW, Redecha P,Monestier M,MackmanN,Girardi G: Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood 114: 1675-1683, 2009
11. Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T: De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant 10: 1804-1811, 2010
12. Chapin J,Weksler B,Magro C, Laurence J: Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura. Br J Haematol 157: 772-774, 2012
13. Barnett AN, Asgari E, Chowdhury P, Sacks SH, Dorling A, Mamode N: The use of eculizumab in renal transplantation. Clin Transplant 27: E216-E229, 2013
14. Wilson CH, Brown AL,White SA,Goodship TH, SheerinNS,ManasDM: Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab. Transplantation 92: e42-e43, 2011
15. Hadaya K, Ferrari-Lacraz S, Fumeaux D, Boehlen F, Toso C, Moll S, Martin PY, Villard J: Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant 11: 2523-2527, 2011
16. Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F: Eculizumab in severe Shiga-toxin-associated HUS. N Engl JMed 364: 2561-2563, 2011
17. Nester CM, Brophy PD: Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases. Curr Opin Pediatr 25: 225-231, 2013
18. Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y,Mariat C,Menne J,Moulin B, Nürnberger J,OgawaM, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB,Goodship T, Loirat C: Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368: 2169-2181, 2013
19. Colvin RB: Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18: 1046-1056, 2007
20. Batal I, Girnita A, Zeevi A, Saab BA, Stockhausen S, Shapiro R, Basu A, Tan H, Morgan C, Randhawa P: Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 21: 1490-1498, 2008
21. Kikic Z, Regele H, Nordmeyer V, Wahrmann M, Kletzmayr J, Bartel G, Böhmig GA: Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Transplantation 91: 440-446, 2011
22. Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, Davies SM, Jodele S: Renal arteriolar C4d deposition: A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 96: 217-223, 2013
23. Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, ZhaoMH, Bruijn JA, Bajema IM: Pros and cons for C4d as a biomarker. Kidney Int 81: 628-639, 2012
24. Shen Y, Chen XW, Sun CY, Dai M, Yan YC, Yang CD: Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: A prospective study of 155 cases. Lupus 19: 1195-1203, 2010
25. Mii A, Shimizu A, Kaneko T, Fujita E, Fukui M, Fujino T, Utsumi K, Yamaguchi H, Tajika K, Tsuchiya S, Iino Y, Katayama Y, Fukuda Y: Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Pathol Int 61: 518-527, 2011
26. Chang A: Thrombotic microangiopathy and the kidney: A nephropathologist's perspective. Diagn Histopathol 19: 158-165, 2013
27. de Vries DK, van der Pol P, van Anken GE, van Gijlswijk DJ, Damman J, Lindeman JH, Reinders ME, Schaapherder AF, Kooten C: Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation. Transplantation 95: 816-820, 2013
28. Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183: 2343-2348, 1996
29. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore FD Jr, Carroll MC, Hechtman HB: Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) 86: 938-942, 1999
30. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM: A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63: 134-142, 2003
31. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8: 753-760, 2008